JOLENE K MANUYAG: Open Payments
NPI 1790313674 · HINSDALE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,132 in 84 payments from 18 companies in 2025. Trend: 2023 $1,296 · 2024 $1,331 · 2025 $3,132
Food & beverage: $1,768Consulting: $1,215Travel & lodging: $149
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 14 | $1,698 |
| ABBVIE INC. | 21 | $300 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $287 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $154 |
| Janssen Biotech, Inc. | 4 | $99 |
| Ardelyx, Inc. | 4 | $90 |
| Gilead Sciences, Inc. | 3 | $84 |
| Phathom Pharmaceuticals, Inc. | 3 | $71 |
| Novo Nordisk Inc | 2 | $50 |
| Lilly USA, LLC | 2 | $48 |
Products named: REZDIFFRA, ENTYVIO, RINVOQ, XIFAXAN, TREMFYA, IBSRELA, VOQUEZNA, DUPIXENT.
Industry payments across IL — which companies pay providers there.
